NCT04975750

Brief Summary

The overall aim of this randomized controlled trial is to evaluate the effectiveness of a problem-solving intervention for the prevention of sick leave among employees with early signs of CMDs. The intervention is delivered by first-line managers and a 30% reduction in sick leave days is expected in the experimental condition compared to treatment-as-usual, during the 12- months follow-up.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 23, 2021

Completed
24 days until next milestone

Study Start

First participant enrolled

August 16, 2021

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 27, 2024

Status Verified

March 1, 2024

Enrollment Period

3.4 years

First QC Date

July 14, 2021

Last Update Submit

March 26, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sick leave

    The total number of days on sick leave due to CMDs (including the first 14 calendar days compensated by the employer) during the 12 month follow-up period

    From baseline until 12 months

Secondary Outcomes (8)

  • Work performance

    From baseline until the 12-month follow-up

  • Work ability

    From baseline until the 12-month follow-up

  • Self-rated general health

    From baseline until the 12-month follow-up

  • Depressive and anxiety symptoms

    From baseline until the 12-month follow-up

  • Self-rated exhaustion

    From baseline until the 12-month follow-up

  • +3 more secondary outcomes

Other Outcomes (3)

  • General self-efficacy

    From baseline until the 12-month follow-up

  • Manager support

    From baseline until the 12-month follow-up

  • Job control

    From baseline until the 12-month follow-up

Study Arms (2)

Problem solving intervention

EXPERIMENTAL

Problem solving as developed by Nexu and colleguages. First-line managers are trained in the problem solving intervention (1 1/2 day). Thereafter, they apply the problem-solving in 2 - 5 meetings (about 30 - 45 min each) with employees at risk of future sick leave due to common mental disorders.

Behavioral: Problem solving intervention

Care as usual

ACTIVE COMPARATOR

First-line managers participate in a 3 hour lectur including a brief overview about worker health, occupational stress and the mismatch model and self-efficacy. Thereafter, they provide care-as-usual to employees at risk of future sick leave due to common mental disorders.

Behavioral: Care as usual

Interventions

The intervention focuses on the individual employee and his/her work situation and work-private life balance. The following steps are implemented: inventory and prioritization of problems; brainstorming options and solutions; formulation of an action plan; evaluation, and follow-up. The intervention is carried out in about 3 planned meetings (30 - 45 min) between the manager and the employee. However, given the lack of research regarding the intervention delivered to this specific population and which dose that should be considered as beneficial as well as the complexities of the identified problems, the number of meetings is not specified

Problem solving intervention
Care as usualBEHAVIORAL

The managers and the employee have meetings regarding the employee and his/her work situation and work-private life balance. However, the managers are not educated in and do not use the problem solving intervention. They are instead instructed to use their usual procedures.

Care as usual

Eligibility Criteria

Age18 Years - 59 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • scoring with a cut-off ≥3 points on the GHQ-12, or a positive answer on the question on risk of SA, namely employee believes that he/she will receive a sickness certification due to stress, anxiety, or depression the following 12 months.
  • negative answer on the question on bullying, namely employee has not been exposed to bullying by his or her first line manager.
  • understand written and spoken Swedish.

You may not qualify if:

  • Ongoing sick leave (full- or part-time), leave of absence, pregnancy.
  • Sick leave ≥14 calendar days during the last 3 months due to CMD.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet

Stockholm, 17177, Sweden

Location

Related Publications (1)

  • Bjork Bramberg E, Arapovic-Johansson B, Bultmann U, Svedberg P, Bergstrom G. Prevention of sick leave at the workplace: design of a cluster-randomized controlled trial of a problem-solving intervention among employees with common mental disorders. BMC Public Health. 2021 Sep 26;21(1):1756. doi: 10.1186/s12889-021-11786-6.

MeSH Terms

Conditions

Mental Disorders

Study Officials

  • Elisabeth Björk-Brämberg@ki.se, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Docent, Associate Professor, PhD

Study Record Dates

First Submitted

July 14, 2021

First Posted

July 23, 2021

Study Start

August 16, 2021

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

March 27, 2024

Record last verified: 2024-03

Locations